MENU
ACRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aclaris Therapeutics (ACRS) Earnings Date & Reports

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States... Show more

A.I. Advisor
published Earnings

ACRS is expected to report earnings to rise 7.69% to -14 cents per share on November 05

Aclaris Therapeutics ACRS Stock Earnings Reports
Q3'25
Est.
$-0.14
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.72
Q3'24
Missed
by $0.10
The last earnings report on August 07 showed earnings per share of -12 cents, beating the estimate of -14 cents. With 635.70K shares outstanding, the current market capitalization sits at 176.50M.
View a ticker or compare two or three
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACRS showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of novel dermatological therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
701 Lee Road
Phone
+1 484 324-7933
Employees
91
Web
https://www.aclaristx.com